Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. (Record no. 24991704)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01871 a2200553 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517035642.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201604s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1748-6963 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.2217/nnm.15.50 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Su, Xiao |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20160421 |
| 245 00 - TITLE STATEMENT | |
| Title | Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Nanomedicine (London, England) |
| Date of publication, distribution, etc. | 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2033-50 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ATP Binding Cassette Transporter, Subfamily B, Member 1 |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibiotics, Antineoplastic |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ceramides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Doxorubicin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Combinations |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Synergism |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucosyltransferases |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Liposomes |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polyethylene Glycols |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Up-Regulation |
| General subdivision | drug effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Song, Hao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Niu, Fangfang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yang, Kaixuan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kou, Geng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Xiaohang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chen, Huaiwen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Wei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guo, Shangjing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Jun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Bohua |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feng, Si-Shen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jiang, Jianxin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yin, Chuan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gao, Jie |
| 773 0# - HOST ITEM ENTRY | |
| Title | Nanomedicine (London, England) |
| Related parts | vol. 10 |
| -- | no. 13 |
| -- | p. 2033-50 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.2217/nnm.15.50">https://doi.org/10.2217/nnm.15.50</a> |
| Public note | Available from publisher's website |
No items available.